McFarlane Neil F. (CIK 1681098) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-10). Recent activity: Buy ZVRA (37,500 shares), Sell ZVRA (14,625 shares), Buy ZVRA (233,334 shares), Sell ZVRA (91,000 shares), Buy ZVRA (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO | Buy | 37,500 | $0 |
| 2026-02-10 | ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO | Sell | 14,625 | $125,190 |
| 2026-02-02 | ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO | Buy | 233,334 | $0 |
| 2026-02-02 | ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO | Sell | 91,000 | $853,580 |
| 2025-10-10 | ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO | Buy | 50,000 | $0 |
| 2025-10-10 | ZEVRA THERAPEUTICS, INC. (ZVRA) | President and CEO | Sell | 19,500 | $210,990 |
来源：SEC Form 4 申报文件 · 截至 2026-02-10